Marion Wealth Management Buys 545 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Marion Wealth Management raised its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,766 shares of the financial services provider’s stock after acquiring an additional 545 shares during the period. Marion Wealth Management’s holdings in iShares Biotechnology ETF were worth $2,613,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Choreo LLC boosted its stake in iShares Biotechnology ETF by 54.9% in the second quarter. Choreo LLC now owns 3,465 shares of the financial services provider’s stock worth $475,000 after purchasing an additional 1,228 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in iShares Biotechnology ETF by 9.6% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 24,424 shares of the financial services provider’s stock worth $3,352,000 after acquiring an additional 2,141 shares during the last quarter. Lyell Wealth Management LP grew its holdings in iShares Biotechnology ETF by 0.7% during the 2nd quarter. Lyell Wealth Management LP now owns 21,539 shares of the financial services provider’s stock worth $2,956,000 after acquiring an additional 145 shares during the last quarter. Williams Financial LLC acquired a new stake in iShares Biotechnology ETF in the 2nd quarter valued at about $867,000. Finally, One Capital Management LLC acquired a new position in shares of iShares Biotechnology ETF during the second quarter worth approximately $400,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock traded up $1.29 during midday trading on Monday, reaching $134.02. The company had a trading volume of 1,445,013 shares, compared to its average volume of 1,451,204. The stock has a fifty day simple moving average of $137.95 and a 200 day simple moving average of $141.99. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.